Finzati - Logo
PRPH logo

ProPhase Labs, Inc.

PRPHMedical - Pharmaceuticals
$0.02
0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$280,324
Growth
-0.7%
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 23, 2026, 12:10 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.02
Change0.00%
Market Cap$280.32K
Beta0.13
Gross Margin31.85%
Oper. Margin-4.15%
Profit Margin-3.39%
Debt/Eq0.00
Current Ratio0.00
Quick Ratio0.00
Revenue 5Y-0.72%
Target$140.00

Investment DNA

How strong this company looks for long-term investors

38
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
23/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Manageable debt level · 0Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-23
Low
$140.00
Mean
$140.00
Median
$140.00
High
$140.00

Company Overview

IPO: 4/4/1994
Industry: Medical - Pharmaceuticals
P/B i: 0.00
Debt / Equity i: 0.00
Operating Margin: -415.35%
Net Margin: -339.31%
ROE i: -
ROIC: -

Financial Health

Score5 / 20
Debt / Equity: 0.00
Current Ratio: 0.00
Quick Ratio: 0.00
Status: Weak

Insider Transactions

Recent executive and insider activity

1 high-volume insider sell detected
Abenante Carolina
Transaction: 06/20/2025
OTHER
Change
0
Price
Not reported
Filing
11/10/2025
Type
OTHER
Karkus Ted William
Transaction: 09/09/2025
BUY
Change
+500,000
Price
$0.60
Filing
09/11/2025
Type
BUY
Hollenshead Stuart
Transaction: 02/17/2025
BUY
Change
+500,000
Price
$0.60
Filing
02/21/2025
Type
BUY